Drugs / famotinib
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07466901 | Apr 2026 → Apr 2030 expected | cervical cancer | Jin Li | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | famotinib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07466901 ↗ |
| Route | Oral | “10mg, oral administration, QD” NCT07466901 ↗ |